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Abstract 
Background: Parkinson’s disease (PD) is a common and complex neurological problem. Gait 
abnormalities are frequent in PD patients, and this increases the risk of falls. However, little is known 
about foot deformities and footwear in this vulnerable population. Here we investigate whether patients 
with PD use an appropriate shoe size and know if they have foot deformities or alterations. 
Methodology: A study of a series of observational descriptive cases in a convenience sample (n = 53 
patients) diagnosed with Parkinson’s disease. One trained investigator evaluated foot and ankle health. 
The footwear and foot measurements were obtained using a Brannock device. 
Results: The podiatric examination and footwear examination detected a high presence of podiatric 
pathologies and inappropriate footwear. This has a negative impact on the quality of life of these patients. 
Conclusions: This research detected an elevated number of people with foot deformities or alterations. 
Moreover, a high proportion of participants with PD wear inadequate footwear (in length, width, or 
both). 
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Introduction 
Parkinson’s disease (PD) is the most frequent 
movement disorder and represents, after Alzheimer’s 
disease, the principal neurodegenerative problem 
related to the central nervous system [1]. PD affects 
1% of people > 60 years old and has a prevalence of 
3% among those > 80 years old [2]. The PD population 
is expected to increase by more than 50% by 2030 [3], 
costing the European healthcare system an estimated 
9000 million [4]. 
The risk factor best associated with the 
beginning of PD is age. Genetics plays a role in those 
where the disease manifests before 50 years old [5,6]. 
Tobacco smoking is associated with a lower risk of 
PD, even though the mechanism of this relationship 
remains unknown [7,8]. Other risk factors 
(environmental exposures, melanoma, diabetes, 
hypertension, alcohol, high milk and dairy 
consumption, and obesity) and protective (caffeine 
consumption, vitamin E, a non-steroidal anti- 
inflammatory drug, urate, physical activity of 
intensity moderate, calcium channel blocker, and 
statins) present contradictory results [9,10]. 
Today, PD is understood as a multifactorial 
condition with idiopathic etiopathogenesis [11]. Its 
onset is insidious, which makes it complicated to 
diagnose in the initial stages, starting unilaterally [12]. 
The crucial pathological feature of PD is the decrease 








compacta; another hallmark is Lewy pathology, the 
protein α-synuclein accumulates abnormally inside in 
cell body and degenerates neurons of the nervous 
system [13]. These results in a movement disorder 
characterized by the following motor signs: tremor, 
bradykinesia, muscular rigidity, and postural 
instability [14]. 
The relationship between foot symptoms and PD 
include alterations in the cycle of gait, characterized 
by a decrease in stride length [15]. PD patients 
manifest significant differences in heel contact and a 
lowered foot uprising during the swing phase [16]; 
hence they have an elevated risk of falling [17]. This is 
exacerbated among people who have freezing of gait 
(FOG) [18]. 
Falls represent an important problem. Between 
60 and 70% of persons with PD fall each year, with 
social and health consequences, including reduced 
quality of life and increased hospitalization, fractures, 
health spending, and mortality [19]. 
Postural instability responds poorly to drug 
therapy, so it is essential to investigate new action 
strategies. Recent research shows that plantar foot 
stimulation has a positive effect on the step and stride 
length and has a positive effect on walking stability 
[20]. A type of mechanical foot and ankle device has 
been shown to improve walking and decrease the 
recurrence of FOG [21]. The range of motion (ROM) of 
the ankle is altered, so performing therapeutic actions 
on this joint will help improve the cycle of gait [22]. 
Foot dystonia is frequent and might appear at 
the beginning of PD as an initial manifestation of the 
disease, inducing an abnormal posture with inversion 
of the foot and extension of the Hallux [23]. This 
negatively affects the quality of life, producing pain 
and making it difficult to wear footwear [24]. 
Although botulinum toxin is routinely used as a 
therapeutic, more studies are needed to support the 
notion that this is an effective treatment [25,26]. 
Foot problems affect posture and can induce falls 
among the elderly [27,28]. We found only one study 
that addresses this topic. The authors used of a 
22-question survey and found that half suffer from 
foot problems, and a third find it difficult to wear 
footwear [29]. Also, no studies have analyzed 
footwear, which can alter gait patterns in people and 
is recognized as a modifiable risk factor in falls 
prevention [30,31]. Because of this, laser shoes have 
been designed to alleviate FOG, offering a promising 
intervention in the future [32]. 
Here we analyze whether patients with PD use 
an appropriate shoe size and are knowledgeable 
about whether they have foot deformities or 
alterations. Our hypothesis is that patients with PD 
present foot disorders and wear inadequate footwear. 
Materials and Methods 
Design 
Study of a series of observational descriptive 
cases [33], describing the state of health of the foot and 
its relationships with footwear, to monitor their health 
in patients with PD. 
Sample 
Fifty-three subjects diagnosed with PD 
participated in the study between 28 January 2020 and 
3 March 2020. Participants were recruited by 
convenience sampling. 
Inclusion criteria consisted: signed informed 
consent, individuals diagnosed with PD by their 
specialist physician and not having compromised 
balance. Individuals that are in stage I and II, 
according to Hoehn and Yahr stage. The exclusion 
criteria include having a significant cognitive 
impairment that prevents them from consenting to 
participate in the study and understanding the 
guidelines of the test indicated, or having a surgical 
history of the lower limb or a recent fracture that 
prevents the person from performing the study. 
Procedure 
One trained investigator picked up the 
measurements, following the protocol of previous 
studies in other vulnerable populations, such as 
people with Alzheimer’s disease and rheumatoid 
arthritis [34,35]. 
Initial measures of the participants include: 1) 
demographic variables (age and gender); 2) 
anthropometric variables (height in centimeters, 
weight in kilograms, with the patient in orthostatic 
position and barefoot); and 3) variable body mass 
index (BMI) calculated from the height in meters and 
weight in kilograms applying Quetelet’s equation 
(BMI = weight / height2) [36]. 
A physical examination of the foot and ankle 
was carried out to determine the presence of podiatric 
pathologies. The general health of the foot was 
evaluated, observing the state of the skin, and giving 
attention to the presence of hyperkeratosis or nail 
diseases [37]. 
ROM of the first metatarsophalangeal joint (one 
MTP) was assessed using a goniometer [38]. 
Functional Hallux Limitus was considered present 
when one MTP did not reach 65º in extent. Hallux 
Rigidus was considered present when there is no 
movement in the extension of one MTP or this plus 
less than 10º. In parallel, the ROM of the ankle joint 
(AJ) to dorsiflexion was assessed using the 
Silfverskiöld test [39]. Equinus deformity was 




considered present when AJ did not possess 10º at 
dorsiflexion. 
The presence of Hallux Abductus Valgus (HAV) 
and digital deformities were tested with the patient in 
a bipedal position. The Manchester Scale [40] was 
used to catalog HAV deformity. This clinical stopover 
determines four levels of HAV: none, mild, moderate, 
and severe. It shows excellent interobserver reliability 
and, in contrast to radiographs, shows high interrater 
reliability (intraclass interrelation coefficient bigger 
than 0.96) [41]. 
We measured both the foot and the shoe size 
using a Brannock device, a validated measuring 
instrument (MedicalTtrain; Madrid, Spain). The foot 
exploration consisted of assessing the longitude and 
broadness of the foot using the validated Brannock 
device [42]. This instrument has been shown to be 
safe, with an intraclass interrelation coefficient of 
0.96–0.99 [43]. Every patient remained in an 
orthostatic position, barefooted, and with their weight 
evenly distributed, with the objective of ensuring that 
the tissues of the foot have extended and feet acquired 
maximum size. The investigator put the foot of the 
patient in the device, with the heel positioned in the 
heel cup. Then, a moveable arch length pointer is 
placed in the first metatarsal head. The highest 
number is then used in the moveable width bar. An 
identical protocol was used to evaluate the other foot, 
as well as to analyze shoe size. 
The sample size was calculated with a statistic 
calculator designed by Unidad de Epidemiología 
Clínica y Bioestadística [44]. The calculations took into 
account the number of individuals with PD in the 
autonomous community of Galicia, which has a total 
population of 2,699,499 [45], with 4.91% of the 
population having PD [46]. 
To estimate a predominance of pathologies in the 
ankle-foot complex of 50% (p = 0.5) with a confidence 
level of 95% (α = 0.05), the precision of ± 14% and 
assuming an information loss of 8%, it is necessary to 
evaluate 53 people. 
Statistical Analysis 
Statistical analyses were performed using SPSS 
24.0 (IBM Corp, Armonk, NY, USA). P-values < 0.05 
were considered statistically significant. 
Sociodemographic and anthropometric variables 
were inquired for normal distribution using the 
Kolmogorov-Smirnov test, and data were considered 
normally distributed if p > 0.05. An independent 
Student t-test was carried out to find if differences 
between man and woman with PD were statistically 
significant in age, height, weight, and BMI. 
Categorical variables appear as total values and 
percentages, while the quantitative variables are 
represented as mean, standard deviation, and 
maximum and minimum values. The Chi-squared (χ2) 
test was used to collate the categorical variables of 
foot and shoe measurements. 
Ethical Considerations 
This investigation was authorized by the 
Research and Ethics Committee of the University of 
Coruña, file number 2019-0018. This study followed 
the principles of the Declaration of Helsinki, and the 
Oviedo Convention. 
Each patient was given a document on the 
characteristic of the study, and they had the 
opportunity to clarify any doubts with the researcher. 
Also, all participants gave their informed consent, 
participating freely and voluntarily in the study. 
Results 
Demographic and anthropometric variables 
show a normal distribution (p > 0.05). Fifty-three 
patients finished every phase of the investigation 
process, 36 of whom were male (67.9%) and 17 female 
(32.1%), with a mean (± SD) age of 68.15 ± 9.73 years 
(range, 42 to 89 years old). 
We observed statistically significant differences 
(p < 0.05) in age, body weight, and stature, but no 
significant differences in BMI, in which overweight is 
observed (mean = 27.85 ± 3.63). The initial 
measurements of the participants are given in Table 1.  
The podiatric examination detected that 88.68% 
(n = 47) of the participants present some type of 
podiatric pathology. The physical examination of the 
skin revealed that 71.7% (n = 38) had nail disorders or 
hyperkeratosis; the physical examination of the joints 
showed that 56.6% (n = 30) had hallux limitus 
functional, 24.5% (n = 13) had hallux rigidus, 71.7% (n 
= 38) had ankle equinus, and 45.3% (n = 24) had 
hallux abductus valgus and deformed toes. 
 
Table 1. Variables sociodemographic and anthropometric of the sample with PD 
 Total group mean ± SD (n=53) Male mean ± SD (n=36) Female mean ± SD (n=17) p-value* 
Age (years) 68.15± 9.73 (42-89) 69.97 ± 9.25 (48-89) 64.29 ± 9.99 (42-89) 0.047 
Weight (years) 75.87 ± 10.92 (52-96) 78.56 ± 9.48 (61-95) 70.18 ± 11.84 (52-96) 0.008 
Height (m) 165.06 ± 8.49 (150-183) 168.78 ± 7.34 (155-183) 157.76 ± 5.36 (150-169) 0.000 
BMI (kg/m2) 27.85 ± 3.63 (22.51-39.45) 27.57 ± 2.75 (22.84-34.89) 28.43 ± 5.07 (22.51-39.45) 0.518 
Abbreviations: BMI, body mass index; SD, standard deviation; Mean ± SD, range (minimum – maximum). In all the analyses p < 0.05 (with a 95% confidence interval) was 
considered statistically significant. *Students’ t test for independent samples was used for the analysis data. 





After metering foot and footwear size, we 
determine that 75.5% (n = 40) of participants for the 
right foot and 60.4% (n = 32) of participants for the left 
foot use inadequate footwear, either in length, width, 
or both. As shown in Table 2, on the right and left 
feet, 41.5% (n = 22) and 26.4% (n = 14) wear 
appropriate footwear in length but not in width. Only 
24.5% (n = 13) (on the right foot) and 39.6% (n = 21) 
(on the left foot) of participants used properly sized 
footwear. 
 
Table 2. Foot and shoe measurements 







Right foot     0.025 
Shoe size too big 3 9 3 15 
Correct shoe size 1 13 22 36 
Shoe size too small 0 0 2 2 
Total 4 22 27 53 
Left foot     0.137 
Shoe size too big 2 10 3 15  
Correct shoe size 2 21 14 36  
Shoe size too small 0 0 2 2  
Total 3 31 19 53  
Note: In all the analyses p < 0.05 (with a 95% confidence interval) was considered 
statistically significant. 
*Chi-squared test was used. 
 
Discussion 
The results of this research detected that 
participants have a high presence of foot deformities 
and use inappropriate footwear. 
Our results are in line with the findings of 
previous podiatry studies in other vulnerable 
populations relating to footwear and foot health, by 
means of podiatric examination. The results are in line 
with the study by Bowen et al., which reported that 
53% of 218 respondents with PD have foot problems. 
Also, Son et al. observed a decrease in the ROM of the 
ankle joint when analyzing the kinematics of gait; this 
is consistent with the results of our study, in which 
71.7% have equinus ankle. 
Various authors [47-49] state that the use of 
incorrectly sized footwear in length and width 
measurements is significantly associated with poor 
foot health, decreased quality of life, and increased 
pain, foot deformities, dermatological alterations, and 
falls. They also indicated that a large proportion of the 
population, around 63–72%, is wearing improperly 
sized footwear (in length and width measurements) 
[50]. These findings are consistent with our results, 
where 75.5% (right foot) and 60.4% (left foot) of 
participants use inappropriate footwear, and a high 
proportion has a foot deformity. 
The results are consistent with other similar 
studies in aging populations without Parkinson’s. For 
example, Tovaruela et al. state that 84.93% of a total of 
166 patients with rheumatoid arthritis have foot 
problems, and only 38.5% are using appropriate 
footwear. Also, López et al. [51], in an aged sample 
with 100 participants, reported that 88% suffer from 
foot problems, and 83% use inappropriate footwear. 
Finally, Harrison et al. [52] reported in 100 diabetic 
patients that only 20% use appropriate footwear, 
according to measurement length and width. 
Furthermore, several studies have reported an 
increase in podiatric pathologies with aging [53,54]. In 
our study, the podiatric examination detected that 
88.68% of the participants present some type of 
podiatric pathology. 
Approximately 70% of falls have intrinsic causes, 
such as turning and improper stepping, aggravated 
by a low sensory innervation of the foot. It is known 
that the presence of podiatric pathologies increases 
the risk of falls [55]. 
The research has some limitations. First, the 
sample size is small; it would be beneficial to include 
participants all over Spain that strengthen the results 
of the study and might recognize more variables 
involved. Second, despite having performed a sample 
size calculation, it would be advantageous to have 
carried out a previous pilot study, which might have 
improved the quality of the study. Third, only one 
investigator analyzed the variables of participants; 
future investigations would involve a minimum of 
two investigators, one for podiatric examination and 
another for footwear exploration. Finally, data 
contrast with a control group without PD would 
strengthen the data. The absence of information about 
demographics characteristics and podiatric history 
should be taken into account. 
Thus, podiatrists have an important role among 
this vulnerable population, which includes 
developing prevention programs, podiatry, and 
footwear education. All this will have an assertive 
impact on foot health and welfare in this vulnerable 
population. Additionally, shoe companies must 
dispose of an appropriately wide selection of 
footwear that allows accommodating the real 
morphology of the foot, especially in the transverse 
arch. We propose that a wider range of widths for 
each shoe should be available, so that it allows 
accommodating feet with wider dimensions. 
This study provides novel data on the presence 
of foot deformities and footwear in people with PD. 
Further studies are needed for diverse strategies and 
interventions that enhance the general health and foot 
health in people with PD. 
Conclusions 
This research detected an elevated number of 
people with foot deformities or alterations. Moreover, 




a high presence of participants with PD wears 
inadequate footwear in length, width, or both. 
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